化学原料及化学制品制造业
Search documents
天原股份:关于公司及子公司开展外汇衍生品交易的公告
Zheng Quan Ri Bao· 2026-01-16 15:20
Core Viewpoint - Tianyuan Co., Ltd. announced the approval of a proposal to engage in foreign exchange derivative trading with a limit of up to 50 million USD for a duration of 12 months [2] Group 1: Company Announcement - The company will hold the 23rd meeting of the 9th Board of Directors on January 16, 2026, to review the proposal [2] - The types of foreign exchange derivative transactions include forward foreign exchange contracts, foreign exchange trading, foreign exchange options, currency swaps, and foreign exchange interest rate swaps, as well as combinations of these products [2]
三美股份:公司正积极推进浙江三美研发中试基地项目建设
Zheng Quan Ri Bao Wang· 2026-01-16 15:14
证券日报网讯1月16日,三美股份(603379)在互动平台回答投资者提问时表示,公司重视第四代发泡 剂、制冷剂的研发与产业化布局,正积极推进浙江三美研发中试基地项目建设。 ...
合盛硅业:因信披违规被责令整改 公司高度重视并引以为戒
Zhong Guo Zheng Quan Bao· 2026-01-16 13:49
因未按规定披露关联交易及战略合作框架协议事项,合盛硅业(603260)1月16日晚间发布关于公司及 相关责任人收到浙江证监局行政监管措施决定书的公告。 公告显示,公司于1月16日收到浙江证监局出具的《关于对合盛硅业股份有限公司采取责令改正监督管 理措施的决定》并对相关责任人出具《警示函》。 公司强调,本次监管措施不会影响公司正常生产经营管理活动,公司将严格按照有关法律法规的规定和 要求,认真、及时履行信息披露义务。(王珞) 公司表示,在浙江证监局查明上述事实后,公司管理层及相关责任人对此事高度重视,后续将严格按照 行政监管措施决定书的要求对相关问题全面梳理、认真总结并积极整改,在规定的期限内提交书面整改 报告。 公司指出,公司后续将认真吸取教训并引以为戒,切实加强董高及相关人员对《上市公司信息披露管理 办法》等相关法律法规及规范性文件的学习,推动公司合规建设常态化,积极提升公司信息披露质量, 强化规范运作意识,杜绝此类事件的再次发生,切实维护公司及广大投资者的利益,促进公司规范、持 续、健康、稳定发展。 经查,公司存在违反《上市公司信息披露管理办法》的情形。2022至2024年,公司与两家公司在此时间 段发生 ...
PriceSeek重点提醒:万华化学丙烯酸丁酯报价上涨200元
Xin Lang Cai Jing· 2026-01-16 13:37
Group 1 - The core viewpoint of the news is that Wanhua Chemical's price for butyl acrylate in Northeast China has increased by 200 yuan/ton to 8210 yuan/ton, reflecting a 2.5% rise, indicating tightening regional spot supply or strengthening demand [1][5][6] - The price increase of butyl acrylate is beneficial for the entire acrylic acid industry chain, as it is a major derivative of acrylic acid, suggesting that the spot price of acrylic acid is likely to rise in the short term [2][6] - The production profit expansion from butyl acrylate will stimulate the procurement demand for acrylic acid, supporting the upward movement of spot prices, although there is a need to monitor downstream acceptance to avoid potential substitution effects [3][7] Group 2 - The pricing mechanism for bulk commodities is based on big data and pricing models, which can determine transaction settlement prices for specified dates or average prices over specified periods [3][7] - The pricing formula includes an adjustment coefficient and a premium or discount that accounts for logistics costs, brand price differences, and regional price differences [4][8]
北化股份将扩建硝化棉生产线 调整产品结构优化产业布局
Zheng Quan Shi Bao Wang· 2026-01-16 13:32
Core Viewpoint - North Chemical Co., Ltd. plans to invest 296 million yuan to enhance its nitrocellulose production capacity through the construction of a new production line and safety storage project, aiming to optimize product structure and improve core competitiveness [1][2]. Group 1: Investment and Project Details - The company will establish a new production line with an annual capacity of 10,000 tons of nitrocellulose, along with supporting infrastructure, located in Nanchong, Sichuan Province, with a construction period of 24 months [1]. - The funding for the project will be sourced from the company's own resources [1]. Group 2: Market Demand and Product Applications - Nitrocellulose, a high molecular compound, is primarily used in fields such as propellants, inks, adhesives, leather oils, and nail polish, with 90% of civilian nitrocellulose products utilized in the coatings and inks market [1]. - The demand for nitrocellulose in the global market has remained stable, with a notable increase in demand for high-end printing inks in recent years [1][2]. Group 3: Company Background and Performance - North Chemical Co., Ltd. was established in 2002 and has maintained the largest production and sales volume of nitrocellulose globally since 2004, exporting to over 50 countries [2]. - The company reported a revenue of 1.131 billion yuan in the first half of 2025, a year-on-year increase of 23.82%, with nitrocellulose-related products generating 426 million yuan, up 44.03% year-on-year [2]. Group 4: Project Feasibility and Strategic Alignment - The feasibility report indicates a rising demand for export nitrocellulose and stable demand for industrial nitrocellulose used in coatings, with high-end ink applications showing growth potential [3]. - The project aligns with national industrial policies and the company's development strategy, expected to enhance nitrocellulose supply capacity and production safety, thereby improving competitiveness and generating economic and social benefits [3].
宏源药业2025年净利预增119.57%至166.2%
Bei Jing Shang Bao· 2026-01-16 13:20
Core Viewpoint - Hongyuan Pharmaceutical (301246) expects a significant increase in net profit for the year 2025, projecting a range of approximately 113 million to 137 million yuan, representing a growth of 119.57% to 166.2% compared to the previous year [2] Group 1: Financial Performance - The company anticipates a substantial rise in operating performance for 2025 compared to the same period last year [2] - The expected profit growth is primarily driven by the lithium hexafluorophosphate business [2] Group 2: Market Demand - The demand for new energy vehicles continues to grow, contributing positively to the company's performance [2] - There is a rapid increase in demand within the energy storage market, which has significantly improved the profitability of the lithium hexafluorophosphate business [2]
四川美丰:公司严格遵守业绩预告相关披露规定
Zheng Quan Ri Bao· 2026-01-16 12:15
证券日报网讯 1月16日,四川美丰在互动平台回答投资者提问时表示,公司严格遵守业绩预告相关披露 规定,若触及信息披露标准,将于1月31日前披露。 (文章来源:证券日报) ...
鲁北化工:公司在欧盟地区业务收入主要为钛白粉产品销售
Zheng Quan Ri Bao· 2026-01-16 12:15
Group 1 - The core viewpoint of the article highlights that Lubei Chemical's revenue from the European Union (EU) region primarily comes from the sales of titanium dioxide products, accounting for approximately 6% of the company's total export revenue [2] - The company primarily exports directly to EU customers, with secondary sales through third-party traders and agents to the EU market [2]
宏源药业(301246.SZ):预计2025年净利润同比增长119.57%~166.2%
Ge Long Hui A P P· 2026-01-16 12:10
Core Viewpoint - Hongyuan Pharmaceutical (301246.SZ) expects a significant increase in net profit attributable to shareholders for 2025, projecting between 113 million to 137 million yuan, representing a growth of 119.57% to 166.20% year-on-year [1] Financial Performance - The net profit after deducting non-recurring gains and losses is anticipated to be between 82 million to 106 million yuan, indicating a substantial increase of 782.01% to 1,040.17% compared to the previous year [1] - The expected impact of non-recurring gains and losses on the net profit attributable to shareholders is approximately 31 million yuan [1] Business Drivers - The significant growth in operating performance for 2025 is primarily driven by the lithium hexafluorophosphate business [1] - The demand in the new energy vehicle market and the rapid growth in the energy storage market have notably improved the profitability of the company's lithium hexafluorophosphate business [1]
北化股份拟2.96亿元投资建设硝化棉生产线项目
Zhi Tong Cai Jing· 2026-01-16 12:00
Core Viewpoint - The company, Beihua Co., Ltd. (002246.SZ), plans to invest 296 million yuan to enhance its nitrocellulose production capacity through a new production line and safety storage project in Nanchong, Sichuan Province, aimed at supporting product structure adjustment and optimizing industrial layout, thereby strengthening core competitiveness and value creation ability [1] Investment Plan - The investment amount is 296 million yuan [1] - The project will be implemented in Nanchong, Sichuan Province [1] Strategic Goals - The initiative aims to support product structure adjustment [1] - The project is intended to optimize the industrial layout [1] - The investment is expected to enhance the company's core competitiveness and value creation ability [1]